Capricor Therapeutics faces a class action lawsuit alleging it made false statements about the progress of its drug deramiocel towards FDA approval. The lawsuit claims the company misled investors by promoting positive trial results while knowing of adverse data from its Phase 2 HOPE-2 trial. Shareholders who bought Capricor shares between October 9, 2024, and July 10, 2025, are encouraged to join the case to recover losses. There is no cost to participate, and the law firm will provide updates throughout the case.
Capricor Therapeutics faces a class action lawsuit alleging securities law violations. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 22, 2026 12:31 WIB: out of 95 priced US health stocks, 43 rose and 49 fell. Notable movers include HRTX at USD 0.30 with a 1-day change of +11.11% and typical hold time of 34 days, BNGO at USD 1.89 with a 1-day change of +9.25% and 90% sell order activity, and DGX at USD 234.00 with a 1-day change of -5.06% and typical hold time of 55 days.
Flutter Entertainment, a leading online sports betting and iGaming operator, will release its third quarter 2026 update on November 4 before the US market opens. The company will host a conference call at 8:30 a.m. ET the same day to discuss the resu...
iPower Inc. declared a 1-for-12 reverse stock split effective October 26, 2026, combining every 12 shares into one to increase the stock price. This move aims to keep iPower's shares compliant with Nasdaq's minimum bid price requirements. Post-split,...
U.S. Global Investors has listed its actively managed U.S. Global Technology and Aerospace & Defense ETF (WAR) on Peru's Lima Stock Exchange, marking the first availability of this ETF outside the U.S. This move gives Peruvian investors access to a f...
Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...
The global Urban Air Mobility (UAM) market is projected to grow from $2.16 billion in 2026 to $16.27 billion by 2035, at a CAGR of 20.9%. This growth is fueled by rising urbanization, traffic congestion, and advances in electric vertical takeoff and ...
